European Heart Journal

دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه

ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
~~قیمت : 3,800,000 تومان~~
قیمت ویژه : 1,900,000تومان

سفارش

Hot topics in congenital heart disease and new insight into ventricular non-compaction

Filippo Crea

doi : 10.1093/eurheartj/ehab746

European Heart Journal, Volume 42, Issue 41, 1 November 2021, Pages 4197–4201

خرید پکیج و مشاهده آنلاین مقاله

Maintaining high standards of clinical research during the Covid-19 pandemic: insights from an excellence clinical research centre

Mattia Lunardi, Darren Mylotte, William Wijns, Yoshinobu Onuma, Osama Soliman, Patrick W Serruys, Faisal Sharif

doi : 10.1093/eurheartj/ehab409

European Heart Journal, Volume 42, Issue 41, 1 November 2021, Pages 4202–4205

خرید پکیج و مشاهده آنلاین مقاله

Retractions in medicine: the tip of the iceberg

Ivan Oransky, Stephen E Fremes, Paul Kurlansky, Mario Gaudino

doi : 10.1093/eurheartj/ehab398

European Heart Journal, Volume 42, Issue 41, 1 November 2021, Pages 4205–4206

خرید پکیج و مشاهده آنلاین مقاله

The “ten commandments” for the 2021 ESC/EACTS Guidelines on valvular heart disease

Alec Vahanian, Fabien Praz, Milan Milojevic, Friedhelm Beyersdorf

doi : 10.1093/eurheartj/ehab626

European Heart Journal, Volume 42, Issue 41, 1 November 2021, Pages 4207–4208

خرید پکیج و مشاهده آنلاین مقاله

Long-term outcomes of new-generation coronary stents in China

Yaling Han

doi : 10.1093/eurheartj/ehab437

European Heart Journal, Volume 42, Issue 41, 1 November 2021, Pages 4209–4211

خرید پکیج و مشاهده آنلاین مقاله

Is tirzepatide in the surpass lane over GLP-1 receptor agonists for the treatment of diabetes?

Francesco Paneni, Carlo Patrono

doi : 10.1093/eurheartj/ehab636

European Heart Journal, Volume 42, Issue 41, 1 November 2021, Pages 4211–4212

خرید پکیج و مشاهده آنلاین مقاله

Transition to adulthood and transfer to adult care of adolescents with congenital heart disease: a global consensus statement of the ESC Association of Cardiovascular Nursing and Allied Professions (ACNAP), the ESC Working Group on Adult Congenital Heart Disease (WG ACHD), the Association for European Paediatric and Congenital Cardiology (AEPC), the Pan-African Society of Cardiology (PASCAR), the Asia-Pacific Pediatric Cardiac Society (APPCS), the Inter-American Society of Cardiology (IASC), the Cardiac Society of Australia and New Zealand (CSANZ), the International Society for Adult Congenital Heart Disease (ISACHD), the World Heart Federation (WHF), the European Congenital Heart Disease Organisation (ECHDO), and the Global Alliance for Rheumatic and Congenital Hearts (Global ARCH)

Philip Moons, Ewa-Lena Bratt, Julie De Backer, Eva Goossens, Tim Hornung, Oktay Tutarel, Liesl Zühlke, John Jairo Araujo, Edward Callus, Harald Gabriel, Nauman Shahid, Karen Sliwa, Amy Verstappen, Hsiao-Ling Yang, Corina Thomet

doi : 10.1093/eurheartj/ehab388

European Heart Journal, Volume 42, Issue 41, 1 November 2021, Pages 4213–4223

The vast majority of children with congenital heart disease (CHD) in high-income countries survive into adulthood. Further, paediatric cardiac services have expanded in middle-income countries. Both evolutions have resulted in an increasing number of CHD survivors. Expert care across the life span is necessitated. In adolescence, patients transition from being a dependent child to an independent adult. They are also advised to transfer from paediatrics to adult care. There is no universal consensus regarding how transitional care should be provided and how the transfer should be organized. This is even more challenging in countries with low resources. This consensus document describes issues and practices of transition and transfer of adolescents with CHD, accounting for different possibilities in high-, middle-, and low-income countries. Transitional care ought to be provided to all adolescents with CHD, taking into consideration the available resources. When reaching adulthood, patients ought to be transferred to adult care facilities/providers capable of managing their needs, and systems have to be in place to make sure that continuity of high-quality care is ensured after leaving paediatric cardiology.

خرید پکیج و مشاهده آنلاین مقاله

Management of acute cardiovascular complications in pregnancy

Gabriele Egidy Assenza, Konstantinos Dimopoulos, Werner Budts, Andrea Donti, Katherine E Economy, Gaetano Domenico Gargiulo, Michael Gatzoulis, Michael Job Landzberg, Anne Marie Valente, Jolien Roos-Hesselink

doi : 10.1093/eurheartj/ehab546

European Heart Journal, Volume 42, Issue 41, 1 November 2021, Pages 4224–4240

The growing population of women with heart disease of reproductive age has been associated with an increasing number of high-risk pregnancies. Pregnant women with heart disease are a very heterogeneous population, with different risks for maternal cardiovascular, obstetric, and foetal complications. Adverse cardiovascular events during pregnancy pose significant clinical challenges, with uncertainties regarding diagnostic and therapeutic approaches potentially compromising maternal and foetal health. This review summarizes best practice for the treatment of common cardiovascular complications during pregnancy, based on expert opinion, current guidelines, and available evidence. Topics covered include heart failure (HF), arrhythmias, coronary artery disease, aortic and thromboembolic events, and the management of mechanical heart valves during pregnancy. Cardiovascular pathology is the leading cause of non-obstetric morbidity and mortality during pregnancy in developed countries. For women with pre-existing cardiac conditions, preconception counselling and structured follow-up during pregnancy are important measures for reducing the risk of acute cardiovascular complications during gestation and at the time of delivery. However, many women do not receive pre-pregnancy counselling often due to gaps in what should be lifelong care, and physicians are increasingly encountering pregnant women who present acutely with cardiac complications, including HF, arrhythmias, aortic events, coronary syndromes, and bleeding or thrombotic events. This review provides a summary of recommendations on the management of acute cardiovascular complication during pregnancy, based on available literature and expert opinion. This article covers the diagnosis, risk stratification, and therapy and is organized according to the clinical presentation and the type of complication, providing a reference for the practicing cardiologist, obstetrician, and acute medicine specialist, while highlighting areas of need and potential future research.

خرید پکیج و مشاهده آنلاین مقاله

Lack of specialist care is associated with increased morbidity and mortality in adult congenital heart disease: a population-based study

Gerhard-Paul Diller, Stefan Orwat, Astrid Elisabeth Lammers, Robert M Radke, Fernando De-Torres-Alba, Renate Schmidt, Ursula Marschall, Ulrike M Bauer, Dominic Enders, Leo Bronstein, Gerrit Kaleschke, Helmut Baumgartner

doi : 10.1093/eurheartj/ehab422

European Heart Journal, Volume 42, Issue 41, 1 November 2021, Pages 4241–4248

The aim of this study was to provide population-based data on the healthcare provision for adults with congenital heart disease (ACHD) and the impact of cardiology care on morbidity and mortality in this vulnerable population.

خرید پکیج و مشاهده آنلاین مقاله

Don’t be alarmed: the need for enhanced partnerships between medical communities to improve outcomes for adults living with congenital heart disease

Abigail D Khan, Anne Marie Valente

doi : 10.1093/eurheartj/ehab281

European Heart Journal, Volume 42, Issue 41, 1 November 2021, Pages 4249–4251

خرید پکیج و مشاهده آنلاین مقاله

Maternal and neonatal complications in women with congenital heart disease: a nationwide analysis

Astrid Elisabeth Lammers, Gerhard-Paul Diller, Rieke Lober, Mareike Möllers, Renate Schmidt, Robert M Radke, Fernando De-Torres-Alba, Gerrit Kaleschke, Ursula Marschall, Ulrike M Bauer, Joachim Gerß, Dominic Enders, Helmut Baumgartner

doi : 10.1093/eurheartj/ehab571

European Heart Journal, Volume 42, Issue 41, 1 November 2021, Pages 4252–4260

The aim of this study was to provide population-based data on maternal and neonatal complications and outcome in the pregnancies of women with congenital heart disease (CHD).

خرید پکیج و مشاهده آنلاین مقاله

Promising perspectives on pregnancy in women with congenital heart disease

Karishma P Ramlakhan, Jolien W Roos-Hesselink

doi : 10.1093/eurheartj/ehab692

European Heart Journal, Volume 42, Issue 41, 1 November 2021, Pages 4261–4263

خرید پکیج و مشاهده آنلاین مقاله

Endocardial/endothelial angiocrines regulate cardiomyocyte development and maturation and induce features of ventricular non-compaction

Siyeon Rhee, David T Paik, Johnson Y Yang, Danielle Nagelberg, Ian Williams, Lei Tian, Robert Roth, Mark Chandy, Jiyeon Ban, Nadjet Belbachir, Seokho Kim, Hao Zhang, Ragini Phansalkar, Ka Man Wong, Devin A King, Caroline Valdez, Virginia D Winn, Ashby J Morrison, Joseph C Wu, Kristy Red-Horse

doi : 10.1093/eurheartj/ehab298

European Heart Journal, Volume 42, Issue 41, 1 November 2021, Pages 4264–4276

Non-compaction cardiomyopathy is a devastating genetic disease caused by insufficient consolidation of ventricular wall muscle that can result in inadequate cardiac performance. Despite being the third most common cardiomyopathy, the mechanisms underlying the disease, including the cell types involved, are poorly understood. We have previously shown that endothelial cell-specific deletion of the chromatin remodeller gene Ino80 results in defective coronary vessel development that leads to ventricular non-compaction in embryonic mouse hearts. We aimed to identify candidate angiocrines expressed by endocardial and endothelial cells (ECs) in wildtype and LVNC conditions in Tie2Cre;Ino80fl/fltransgenic embryonic mouse hearts, and test the effect of these candidates on cardiomyocyte proliferation and maturation.

خرید پکیج و مشاهده آنلاین مقاله